M. Darabantu et al. / Tetrahedron 56 (2000) 3785±3798
3797
on diluted samples only by using RESOLV macro on
VARIAN-Gemini 300, after 128 transients (special atten-
tion was paid to neglect negative peaks). All reactions were
monitored by TLC on MERCK silica gel, by using benzene:
trans-4,12-Diaza-3,11-di(bishydroxymethyl)-1,9-dioxa-
dispiro[4.2.4.2]tetradecane, 5a. 81; 216±217 (DMF);
white crystalline powder. Anal. Calcd for: C H N O
1
4
26
2
6;
found: C 53.00%, H 8.15%, N 8.75%; found: C 52.81%,
H 8.23%, N 8.80%. dC (100 MHz; DMSO-d ) 94.2 (2C,
methanol 3:1 v/v as eluent (visualisation in I bath). The
2
6
p
RHF/3-21G molecular orbital calculations were performed
by using Spartan 5.0 package of programs; Spartan version
C-5, -8), 67.9 (2C, C-3, -11), 66.1 (2C, C-2, -10), 34.5
(4C, C-6, -7, -13, -14), 63.4 (4C, 4£-CH OH).
2
5
3
.0, Wavefunction Inc., 18401 Von Karman Avenue, Suite
70, Irvine, CA 92612, USA.
p
(3R ,11S )-trans-4,12-Diaza-3,11-bishydroxymethyl-3,11-
p
p
dimethyl-1,9-dioxadispiro[4.2.4.2]tetradecane, u-t-5b; (3R ,
p
11R )-trans-4,12-diaza-3,11-bishydroxymethyl-3,11-di-
methyl-1,9-dioxadispiro[4.2.4.2]tetradecane, l-t-5b;
Preparation of mono- and dispiranes (typical procedure)
p
p
TRIS as 0.30±0.50 M suspension in toluene (50 mL) [for
aminodiols 2, 3 in benzene (50 mL)] and cyclic ketone
(3R ,11S )-cis-4,12-diaza-3,11-bishydroxymethyl-3,11-
dimethyl-1,9-dioxadispiro[4.2.4.2]tetradecane, u-c-5b;
p
p
(
molar ratio ketone/TRIS1.5±3.5: 1; for synthesis of
(3R ,11R )-cis-4,12-diaza-3,11-bishydroxymethyl-3,11-
dimethyl-1,9-dioxadispiro[4.2.4.2]tetradecane, l-c-5b. 75;
144±145 (Acetone); white crystalline powder. Anal. Calcd
dispiranes stoichiometric ratio) were stirred under re¯ux
in a Dean±Stark trap until TLC monitoring showed no
more evolution of the reaction (18±21 h). In the case of
monospiranes 4 the crude reaction mixture was neutralised
with solid Na CO and ®ltered hot. The organic solution was
for C14H
N
2
O
4
: C, 58.50%, H, 9.25%, N, 10.00%; found:
26
C, 58.72%, H, 9.15%, N, 9.78%.
2
3
p
(3R ,11S )-trans-4,12-diaza-3,11-diethyl-3,11-bishydroxy-
p
evaporated in vacuo and the residue was crystallised from
an appropriate solvent. Dispiranes 5 were preliminary
isolated as crude products by ®ltering the reaction mixture
at room temperature then recrystallised from an appropriate
solvent. Monospiranes 4d±g and all dispiranes 5 have not
been previously reported. Compounds 4a±c were prepared
p
methyl-1,9-dioxadispiro[4.2.4.2]tetradecane u-t-5c; (3R ,
p
11R )-trans-4,12-diaza-3,11-diethyl-3,11-bishydroxymethyl-
1,9-dioxadispiro[4.2.4.2]tetradecane, l-t-5c. 75; 134±135
(Acetone); grey crystalline powder. Anal. Calcd for
C
61.12%, H, 9.61%, N, 8.91%.
H
16
N
2
O
4
: C, 61.00%, H, 9.71%, N, 9.10%; found: C,
30
8
according to literature.
Yields (%), mp (8C, solvent), elemental analysis and NMR
data (if not collected in Table 3, 4 and 6) are listed below.
References
4
-Aza-3,3-bishydroxymethyl-t-7-methyl-r-1-oxaspiro[4.5]-
1. Aldrichimica Acta 1983, 16, 35.
2. Eachus, A. C. Chim. Oggi 1994, 12, 24±31.
decane and 4-aza-3,3-bishydroxymethyl-c-7-methyl-r-1-
oxaspiro[4.5]decane, 4d. 50; 83±86 (n-heptane); white
crystalline powder. Anal. Calcd for C H NO : C,
3. Bergmann, D. E. Chem. Rev. 1953, 53, 309±352.
4. Pierce, J. S.; Lunsford, C. D.; Raiford Jr., R. W.; Rush, J. L.;
Riley, D. W. J. Am. Chem Soc. 1951, 73, 2595±2596.
5. Pierce, J. S.; Lunsford, C. D. J. Am. Chem. Soc. 1951, 73, 2596±
1
1
21
3
6
9
1.50%, H, 10.05%, N, 6.60%; found: C, 61.37%, H,
.83%, N, 6.50%.
2
598.
4-Aza-3,3-bishydroxymethyl-c-6-methyl-r-1-oxaspiro[4.5]-
decane and 4-aza-3,3-bishydroxymethyl-t-6-methyl-r-1-
6. Cabb, R. U.S. Patent 3,660,488; Chem. Abstr. 1972, 77,
P61258b.
oxaspiro[4.5]decane, 4e. 20; 93±96 (Et O1n-heptane);
2
7. Susi, P. U.S. Patent 4,125,518; Chem. Abstr. 1979, 90,
P72897d.
white crystalline powder. Anal. Calcd for C H NO : C,
1
1
21
3
6
9
1.15%, H, 9.59%, N, 6.45%; found: C, 61.37%, H,
.83%, N, 6.50%. dH (400 MHz; DMSO-d ). Assignment
8. Sokolov, V. B.; Krykov, L. N.; Koloniets; Sololskii, G. A. Zh.
Org. Khim. 1979, 15, 1777±1779.
6
of equatorial position of C-6 methyl group: NOE on doublet
at 0.85 ppm (Me group, d, J5.7 Hz) showed the enhance-
ment of multiplet located in 1.56±1.49 ppm region,
assigned to H , H7a,7e; COSY experiment showed that
9. Buur, A.; Bundgaard, H. Arch. Pharm. Chem. Sci. Ed. 1987, 15,
76±86.
10. Senkus, M. J. Am. Chem. Soc. 1945, 67, 1515±1519.
11. American Cyanamid Co. Br. Patent 564,506; Chem. Abstr.
6
a
3
H10e 1.75 ppm (ddd, J4.5, 4.6 and 13.0 Hz) is coupled
1946, 40, P4084.
12. Hedge, B. E. U.S. Patent 2,433,609; Chem. Abstr. 1948, 42,
P3430h.
with H , H which were located in a different region
1
0a
9a,e
than above, 1.45±1.36 ppm.
13. Cabb, R. U.S. Patent 3,843,726; Chem. Abstr. 1975, 82,
P86193t.
4
4
-Aza-3,3-bishydroxymethyl-1-oxaspiro[4.6]undecane,
f. 90; 91±92 (Et O); white crystalline powder. Anal. Calcd
14. Eastman Kodak. Fr. Patent 1,504,886; Chem. Abstr. 1969, 70,
P57863h.
2
for C H NO : C, 61.50%, H, 9.88%, N, 6.77%; found: C,
21
1
1
3
61.36%, H, 9.83%, N, 6.50%.
15. Schnegelberger, H.; Bellinger, H. German Patent 2,218,348;
Chem. Abstr. 1974, 80, P52285t.
4
-Aza-3,3-bishydroxymethyl-c-8-tertbutyl-r-1-oxaspiro-
4.5]decane and 4-aza-3,3-bishydroxymethyl-t-8-tert-
16. Sidi, H.; Johnson, H. R. Fr. Patent 2,279,828; Chem. Abstr.
1976, 85, P162040v.
[
butyl-r-1-oxaspiro[4.5]decane, 4g. 80; 178±180 (Et O);
white crystalline powder. Anal. Calcd. for C H NO : C,
4
17. Cunningham, A. L., Mathai, J. U.S. Patent 4,101,527; Chem.
Abstr. 1979, 90, P24900e.
2
1
27
3
6
1
5.60%, H, 10.40%, N, 5.50%; found: C, 65.33%, H,
0.57%, N, 5.44%.
18. Tilford, C. H.; Van Campen Jr., M. G.; Shelton, R. S. J. Am.
Chem. Soc. 1947, 69, 2902±2906.